查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1922704

日本藥房零售市場規模、佔有率、趨勢及預測（按市場結構、產品類型、治療領域、藥物類型、藥房位置和地區分類），2026-2034年

Japan Pharmacy Retail Market Size, Share, Trends and Forecast by Market Structure, Product Type, Therapeutic Area, Drug Type, Pharmacy Location, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

日本零售藥局市場在2025年達到1,206億美元。 IMARC Group預測，到2034年，該市場規模將達到1,913億美元，2026年至2034年的複合年成長率為5.26%。推動市場擴張的關鍵因素包括人口老化和慢性病增加、向醫療保健服務和數位化服務的轉型、政府透過國民健康保險制度提供的支持，以及自動化和線上銷售方面的技術進步。

日本藥妝零售市場趨勢：

人口老化和慢性病日益增多

日本零售藥局市場成長要素之一是其快速老化的人口結構，這是全球老化速度最快的國家之一。截至2023年，65歲及以上人口的比例將超過28%，預計到2025年將超過30%。這項人口結構變化顯著增加了對醫療保健服務和藥局相關產品的需求。根據日本厚生勞動省的統計數據，65歲及以上人口中患有糖尿病、高血壓和心血管疾病等慢性病的比例正在上升，導致處方藥需求持續增加。老年消費者越來越依賴藥局，不僅購買處方藥，還購買非處方藥、保健食品、進行健康諮詢和獲得預防保健服務。支撐這一趨勢的是日本健全的國民健康保險（NHI）體系，該體系截至2023年覆蓋了超過96%的人口，使包括醫療保健服務在內的各項醫療保健服務都變得便捷且價格合理。零售藥局正在發展成為綜合健康管理中心，提供宅配服務、用藥諮詢和針對老年消費者需求的先進藥物管理。

技術創新與網路藥局的發展

技術創新和線上藥局的興起正在重塑日本零售藥局市場，並推動其顯著成長。近年來，日本消費者擴大轉向包括線上藥局和健康應用程式在內的數位平台，以便更方便地獲取藥品和醫療保健服務。新冠疫情加速了這一數位轉型，更多消費者選擇遠距醫療，並在線上訂購處方藥和非處方藥。預計日本網路藥局市場規模將在2024年達到64億美元，並在2033年達到205億美元。在數位健康技術創新和消費者對便利性日益成長的需求的推動下，預計2025年至2033年，該市場將以12.4%的複合年成長率成長。網路藥局使消費者能夠在家中訂購藥品、接收電子處方箋並獲得遠端醫療諮詢。政府對數位醫療服務的支持，包括2023年推出的電子處方箋和線上諮詢服務，進一步推動了這項轉型。此外，實體藥局的自動化和機器人技術，例如自動配藥系統和機器人輔助操作，正在提高服務速度和準確性，縮短等待時間，並提升顧客滿意度。

本報告解答的關鍵問題

  • 日本零售藥局市場目前的表現如何？未來幾年又將如何發展？
  • 根據市場結構，日本藥局零售市場是如何分類的？
  • 日本藥妝零售市場的產品類型組成是怎樣的？
  • 日本藥局零售市場依治療領域分類的組成是怎樣的？
  • 日本零售藥局市場依藥品類型分類的組成是怎樣的？
  • 日本藥局零售市場是如何根據藥局位置進行細分的？
  • 日本藥局零售市場按地區分類的情況如何？
  • 請介紹日本藥局零售市場價值鏈的各個環節。
  • 日本藥局零售市場的主要促進因素和挑戰是什麼？
  • 日本藥局零售市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本藥局零售市場的競爭程度如何？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本零售藥局市場－引言

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章 日本藥局零售市場概述

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章 日本藥局零售市場－市場結構分析

  • 雜亂無章
  • 組織

7. 日本藥妝零售市場－依產品類型細分

  • 非處方藥
  • 處方藥
  • 非藥品
  • 醫療設備

第8章：日本零售藥局市場－依治療領域分類

  • 循環系統
  • 止痛藥/止痛劑
  • 維生素、礦物質和營養補充劑
  • 抗感染劑
  • 抗糖尿病藥物
  • 其他

第9章：日本零售藥局市場－依藥品類型分類

  • 學名藥
  • 專利藥品

第10章：日本零售藥局市場－依藥局位置分類

  • 商店類型/購物中心類型
  • 醫院藥房

第11章：日本藥局零售市場：依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第12章：日本零售藥局市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第13章主要企業概況

第14章：日本藥局零售市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第15章附錄

簡介目錄
Product Code: SR112026A35683

The Japan pharmacy retail market size reached USD 120.6 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 191.3 Billion by 2034 , exhibiting a growth rate (CAGR) of 5.26% during 2026-2034 . The aging population with increasing chronic conditions, a shift towards home healthcare and digital services, government support through national insurance programs, and technological advancements in automation and online sales are among the key factors contributing to the market expansion.

JAPAN PHARMACY RETAIL MARKET TRENDS:

Aging Population and Increase in Chronic Conditions

A major growth driver of Japan's pharmacy retail market is the country's rapidly aging population, one of the fastest-aging globally. As of 2023, over 28% of Japan's population was aged 65 or older, and this figure is expected to exceed 30% by 2025. This demographic shift is significantly increasing demand for healthcare services and pharmacy-related products. According to the Ministry of Health, Labor and Welfare, a growing share of adults aged 65 and above in Japan suffer from chronic conditions, such as diabetes, hypertension, and cardiovascular diseases, leading to a steady rise in prescription medication needs. Elderly consumers increasingly depend on pharmacies not only for prescriptions but also for over-the-counter drugs, wellness products, health consultations, and preventive care. Supporting this trend is Japan's robust National Health Insurance (NHI) system, which covered over 96% of the population in 2023, making healthcare, including pharmacy services, both accessible and affordable. Retail pharmacies are evolving into comprehensive health management hubs, offering home delivery, medication counseling, and advanced pharmaceutical care tailored to the needs of aging consumers.

To get more information on this market Request Sample

Technological Advancements and E-Pharmacy Growth

Technological advancements and the rise of e-pharmacies are also reshaping Japan's pharmacy retail market, driving substantial growth. In recent years, Japanese consumers have increasingly turned to digital platforms, including online pharmacies and health apps, to access medications and healthcare services more conveniently. This digital shift, accelerated by the COVID-19 pandemic, has seen more consumers opting for remote consultations and ordering prescription drugs and over the counter (OTC) products online. Japan's e-pharmacy market size reached USD 6.4 billion in 2024 and is expected to reach USD 20.5 billion by 2033, exhibiting a growth rate (CAGR) of 12.4% during 2025-2033, driven by innovations in digital health technologies and growing consumer demand for convenience. E-pharmacies enable consumers to order medications from home, receive digital prescriptions, and access telemedicine consultations. Government support for digital health services, including the introduction of digital prescriptions and online consultations in 2023, has further fueled this transition. Additionally, automation and robotics in physical pharmacies, such as automated dispensing systems and robot-assisted operations, have improved service speed and accuracy, reduced wait times, and enhanced customer satisfaction.

JAPAN PHARMACY RETAIL MARKET SEGMENTATION:

Market Structure Insights:

  • Unorganized
  • Organized
  • Unorganized
  • Organized

Product Type Insights:

  • Access the comprehensive market breakdown Request Sample
  • Over-the-Counter Products
  • Prescribed Drugs
  • Non-Pharmaceutical Products
  • Medical Equipment
  • Over-the-Counter Products
  • Prescribed Drugs
  • Non-Pharmaceutical Products
  • Medical Equipment

Therapeutic Area Insights:

  • Cardiovascular
  • Pain Relief/Analgesics
  • Vitamins/Minerals/Nutrients
  • Anti-Infective
  • Anti-Diabetic
  • Others
  • Cardiovascular
  • Pain Relief/Analgesics
  • Vitamins/Minerals/Nutrients
  • Anti-Infective
  • Anti-Diabetic
  • Others

Drug Type Insights:

  • Generic
  • Patented
  • Generic
  • Patented

Pharmacy Location Insights:

  • Street/Mall Based
  • Hospital Based
  • Street/Mall Based
  • Hospital Based

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan pharmacy retail market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan pharmacy retail market on the basis of market structure?
  • What is the breakup of the Japan pharmacy retail market on the basis of product type?
  • What is the breakup of the Japan pharmacy retail market on the basis of therapeutic area?
  • What is the breakup of the Japan pharmacy retail market on the basis of drug type?
  • What is the breakup of the Japan pharmacy retail market on the basis of pharmacy location?
  • What is the breakup of the Japan pharmacy retail market on the basis of region?
  • What are the various stages in the value chain of the Japan pharmacy retail market?
  • What are the key driving factors and challenges in the Japan pharmacy retail market?
  • What is the structure of the Japan pharmacy retail market and who are the key players?
  • What is the degree of competition in the Japan pharmacy retail market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmacy Retail Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmacy Retail Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Pharmacy Retail Market - Breakup by Market Structure

  • 6.1 Unorganized
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Organized
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)

7 Japan Pharmacy Retail Market - Breakup by Product Type

  • 7.1 Over-the-Counter Products
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Prescribed Drugs
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Non-Pharmaceutical Products
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Medical Equipment
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)

8 Japan Pharmacy Retail Market - Breakup by Therapeutic Area

  • 8.1 Cardiovascular
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Pain Relief/Analgesics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Vitamins/Minerals/Nutrients
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Anti-Infective
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Anti-Diabetic
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2020-2025)
    • 8.6.2 Market Forecast (2026-2034)

9 Japan Pharmacy Retail Market - Breakup by Drug Type

  • 9.1 Generic
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Patented
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)

10 Japan Pharmacy Retail Market - Breakup by Pharmacy Location

  • 10.1 Street/Mall Based
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Hospital Based
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)

11 Japan Pharmacy Retail Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Market Structure
    • 11.1.4 Market Breakup by Product Type
    • 11.1.5 Market Breakup by Therapeutic Area
    • 11.1.6 Market Breakup by Drug Type
    • 11.1.7 Market Breakup by Pharmacy Location
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kansai/Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Market Structure
    • 11.2.4 Market Breakup by Product Type
    • 11.2.5 Market Breakup by Therapeutic Area
    • 11.2.6 Market Breakup by Drug Type
    • 11.2.7 Market Breakup by Pharmacy Location
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/ Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Market Structure
    • 11.3.4 Market Breakup by Product Type
    • 11.3.5 Market Breakup by Therapeutic Area
    • 11.3.6 Market Breakup by Drug Type
    • 11.3.7 Market Breakup by Pharmacy Location
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Market Structure
    • 11.4.4 Market Breakup by Product Type
    • 11.4.5 Market Breakup by Therapeutic Area
    • 11.4.6 Market Breakup by Drug Type
    • 11.4.7 Market Breakup by Pharmacy Location
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Market Structure
    • 11.5.4 Market Breakup by Product Type
    • 11.5.5 Market Breakup by Therapeutic Area
    • 11.5.6 Market Breakup by Drug Type
    • 11.5.7 Market Breakup by Pharmacy Location
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Market Structure
    • 11.6.4 Market Breakup by Product Type
    • 11.6.5 Market Breakup by Therapeutic Area
    • 11.6.6 Market Breakup by Drug Type
    • 11.6.7 Market Breakup by Pharmacy Location
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Market Structure
    • 11.7.4 Market Breakup by Product Type
    • 11.7.5 Market Breakup by Therapeutic Area
    • 11.7.6 Market Breakup by Drug Type
    • 11.7.7 Market Breakup by Pharmacy Location
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Market Structure
    • 11.8.4 Market Breakup by Product Type
    • 11.8.5 Market Breakup by Therapeutic Area
    • 11.8.6 Market Breakup by Drug Type
    • 11.8.7 Market Breakup by Pharmacy Location
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan Pharmacy Retail Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Services Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Services Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Services Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Services Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Services Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Pharmacy Retail Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix